The Blood and Cells Advocacy Roster (BCAR), an industry consortium of blood therapy and cell and gene therapy starting materials stakeholders, launches today to function as a think-tank plus speaker advocacy group. The international organization aims to drive the narrative on the importance of the established blood industry, particularly to help improve patient access to advanced therapies.